Anti-Diabetes Drugs - Morocco | Statista Market Forecast

The Anti-Diabetes Drugs market in Morocco is expected to witness substantial growth in the coming years.
According to projections, the revenue is estimated to reach US$68.29m Moroccan Dirhams in 2024.
This indicates a positive trend in the market, with an annual growth rate (CAGR 2024-2029) of 7.56%.
By 2029, the market volume is anticipated to expand to US$98.32m Moroccan Dirhams.
When compared to the global market, United States is projected to generate the highest revenue in the Anti-Diabetes Drugs market.
In 2024, the revenue United States is estimated to reach a staggering US$37.84bn US Dollars.
This highlights the dominant position of the United States in the global market for Anti-Diabetes Drugs market.
The demand for anti-diabetes drugs in Morocco is steadily increasing due to the rising prevalence of diabetes in the country.

Definition:
The Anti-Diabetes Drugs market covers drugs to treat the metabolism disorder diabetes mellitus. It includes insulin and non-insulinotropic drugs such as glucagen-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors. While patients with type 1 diabetes require lifelong insulin therapy, type 2 diabetes can also be treated with medication.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novo Nordisk, Eli Lilly, Sanofi, Merck & Co

Drugs to treat diabetes mellitus (oral intake and injections)
Insulin
Non-insulinotropic anti-diabetic drugs

Drugs to treat other metabolic disorders or other autoimmune diseases
Lipid-lowering agents
Drugs to treat hypertension
Diagnostics
Devices such as continuous glucose monitors

The Anti-Diabetes Drugs market in Morocco has been steadily growing in recent years.

Customer preferences: Moroccan customers tend to prefer traditional and natural remedies for treating diabetes, such as herbal medicines and dietary changes. However, as the prevalence of diabetes continues to rise in the country, more individuals are turning to pharmaceutical solutions to manage their condition.

Trends in the market: One major trend in the Anti-Diabetes Drugs market in Morocco is the increasing availability of generic versions of popular medications, which has driven down prices and made treatment more accessible for a wider range of patients. Additionally, there has been a shift towards more personalized treatment options, with healthcare providers tailoring drug regimens to individual patients based on factors such as age, weight, and comorbidities.

Local special circumstances: Morocco faces a unique set of challenges when it comes to managing diabetes, including a high prevalence of obesity and a lack of access to quality healthcare in certain regions. Additionally, cultural beliefs and practices such as Ramadan fasting can make it difficult for individuals with diabetes to manage their condition effectively.

Underlying macroeconomic factors: The Moroccan government has made significant investments in healthcare infrastructure and services in recent years, which has helped to improve access to treatment for individuals with diabetes. Additionally, the country's growing middle class and increasing healthcare spending are driving demand for more advanced and personalized treatment options. However, economic instability and political uncertainty could pose challenges for the Anti-Diabetes Drugs market in the future.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

In 2021, diabetes mellitus caused an estimated 1.62 million deaths worldwide, making it the eighth leading cause of death. Furthermore, it is estimated that 537 million people are currently living with diabetes around the world, with this number projected to rise to some 783 million by the year 2045. Diabetes describes a group of metabolic diseases which cause high blood sugar levels. There are three types of diabetes: type 1 diabetes, type 2 diabetes, and gestational diabetes. However, the majority of diabetes cases are type 2, with an estimated 90 to 95 percent of diabetes cases in the United States type 2. Risk factors for type 2 diabetes include being overweight, being physically inactive, being 45 and older, and having prediabetes.